TriVascular Technologies, Inc. Reports Third Quarter Financial Results
November 09, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Nov. 9, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported financial results...
Preliminary Results of the LIFE Study Presented at VIVA 2015
November 03, 2015 12:45 ET
|
TriVascular Technologies, Inc.
Improved Patient Outcomes and Compelling Economic Data with the Ovation® Platform and a Fast-Track EndoVascular Aortic Repair (EVAR) Protocol
SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE)...
Four-Year Results From Global Ovation Pivotal Trial Presented at VIVA 2015
November 03, 2015 12:30 ET
|
TriVascular Technologies, Inc.
Compelling Evidence that the Ovation® System Expands and Improves Endovascular Aortic Repair to More Patients
SANTA ROSA, Calif., Nov. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies,...
TriVascular Technologies, Inc. Reports Preliminary Third Quarter Financial Results
October 26, 2015 16:04 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Oct. 26, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, today reported preliminary...
TriVascular Technologies, Inc. Announces First Patients Treated in Europe With Ovation iX(TM) Abdominal Stent Graft System
September 15, 2015 16:45 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Sept. 15, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the first European patients have been treated successfully with the Ovation iX...
TriVascular Announces First Patient Enrolled in the LUCY Study
August 24, 2015 07:30 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 24, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation® Abdominal Stent Graft platform, announced today the first patient...
TriVascular Technologies, Inc. Reports Second Quarter Financial Results
August 04, 2015 16:02 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, today reported financial...
TriVascular Technologies, Inc. and CRG Modify Term Loan Agreement
August 04, 2015 16:01 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Prime® Abdominal Stent Graft System, and Capital Royalty Partners II...
TriVascular Technologies, Inc. Receives FDA Approval of the Ovation iX(TM) Abdominal Stent Graft System
August 04, 2015 07:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV) announced today that the U.S. Food and Drug Administration (FDA) approved the Ovation iX...
TriVascular Reaches Major Milestones in Key Clinical Studies
August 03, 2015 07:00 ET
|
TriVascular Technologies, Inc.
SANTA ROSA, Calif., Aug. 3, 2015 (GLOBE NEWSWIRE) -- TriVascular Technologies, Inc. (NASDAQ:TRIV), manufacturer of the Ovation Abdominal Stent Graft platform, announced today two major clinical...